文献速递眼底病与葡萄膜炎

糖尿病人类与大鼠视网膜小胶质细胞及Müller细胞中吲哚胺2,3-双加氧酶与喹啉酸表达增加

Increased Indoleamine 2,3-Dioxygenase and Quinolinic Acid Expression in Microglia and Müller Cells of Diabetic Human and Rodent Retina.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

研究比较1型糖尿病(T1D)、2型糖尿病(T2D)患者及年龄匹配非糖尿病供体视网膜,以及T1D大鼠与对照大鼠视网膜中IDO和QUIN的表达与神经元丢失。结果显示糖尿病视网膜小胶质细胞和Müller细胞中IDO与QUIN表达增加,且T1D和T2D视网膜分别出现63%和约43%的NeuN+神经元丢失。作者认为IDO和QUIN表达可能参与糖尿病视网膜病变的神经元变性。

要点

  • T1D和T2D人视网膜中小胶质细胞密度分别增加13%和26%,IDO+小胶质细胞密度与亮度均增加。
  • T1D和T2D人视网膜中CD39+小胶质细胞和VIM+Müller细胞的QUIN+表达强度大幅增加。
  • T1D和T2D人视网膜分别丢失63%和约43%的NeuN+神经元,中央视网膜QUIN+小胶质样细胞分别增加18倍和7倍。

核心结论

  • 作者认为,糖尿病大鼠和人类视网膜中IDO与QUIN的表达可能参与糖尿病视网膜病变特征性的神经元变性。

研究设计与样本

  • 研究纳入T1D(n=7)、T2D(n=13)和20例年龄匹配的非糖尿病人类供体视网膜,以及T1D(n=3)和对照(n=3)大鼠视网膜,采用免疫组织化学检测IDO、QUIN、CD39、Iba-1、Vimentin、NeuN和UEA1凝集素。

主要发现

  • 基于形态学标准,CD39+/Iba-1+驻留小胶质细胞和CD39-/Iba-1+骨髓来源巨噬细胞在T1D(增加13%)和T2D(增加26%)人视网膜中密度高于对照。
  • T1D和T2D人视网膜中IDO+小胶质细胞的密度和亮度均增加。
  • T1D和T2D人视网膜中CD39+小胶质细胞和VIM+Müller细胞的QUIN+表达强度大幅增加。
  • 与 nondiabetic 人视网膜相比,T1D视网膜NeuN+神经元丢失63%,T2D视网膜丢失约43%。
  • 非糖尿病视网膜中QUIN+小胶质样细胞少见,但中央视网膜中T1D增加18倍、T2D增加7倍;T1D大鼠视网膜中IDO+小胶质细胞密度增加2.8倍、亮度增加2.1倍(均与对照相比)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We investigated the relationship between inflammation, neuronal loss, and expression of indoleamine 2, 3-dioxygenase (IDO) and quinolinic acid (QUIN) in the retina of subjects with type 1 diabetes (T1D) and type 2 diabetes (T2D) and in the retina of rats with T1D. METHODS: Retinas from T1D (n = 7), T2D (n = 13), and 20 age-matched nondiabetic human donors and from T1D (n = 3) and control rats (n = 3) were examined using immunohistochemistry for IDO, QUIN, cluster of differentiation 39 (CD39), ionized calcium-binding adaptor molecule (Iba-1, for macrophages and microglia), Vimentin (VIM; for Müller cells), neuronal nuclei (NeuN; for neurons), and UEA1 lectin (for blood vessels). RESULTS: Based on morphologic criteria, CD39+/ionized calcium binding adaptor molecule 1(Iba-1+) resident microglia and CD39-/Iba-1+ bone marrow-derived macrophages were present at higher density in T1D (13% increase) and T2D (26% increase) human retinas when compared with controls. The density and brightness of IDO+ microglia were increased in both T1D and T2D human retinas. The intensity of QUIN+ expression on CD39+ microglia and VIM+ Müller cells was greatly increased in both human T1D and T2D retinas. T1D retinas showed a 63% loss of NeuN+ neurons and T2D retinas lost approximately 43% when compared with nondiabetic human retinas. Few QUIN+ microglia-like cells were seen in nondiabetic retinas, but the numbers increased 18-fold in T1D and 7-fold in T2D in the central retina. In T1D rat retinas, the density of IDO+ microglia increased 2.8-fold and brightness increased 2.1-fold when compared with controls. CONCLUSIONS: Our findings suggest that IDO and QUIN expression in the retinas of diabetic rats and humans could contribute to the neuronal degeneration that is characteristic of diabetic retinopathy.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Hu P, Hunt NH, Arfuso F, et al. Increased Indoleamine 2,3-Dioxygenase and Quinolinic Acid Expression in Microglia and Müller Cells of Diabetic Human and Rodent Retina. Invest Ophthalmol Vis Sci. 2017. PMID: 28980000. doi:10.1167/iovs.17-21654

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。